ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Lunan Pharmaceutical Group clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 39 studies whose lead sponsor is Lunan Pharmaceutical Group or one of 2 companies grouped under it. 19 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 21, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Lunan Pharmaceutical Group with AstraZeneca and Jiangsu HengRui Medicine →

Pipeline: 20 programs

Each counted once: 20 with a study Lunan Pharmaceutical Group leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 5 of 8 with the most live studies.

Program
rulonilimabPhase 3 · 3 live · Neoplasms, Unknown Primary · primary completion Dec 2027☆ Track
BeclomethasonePhase 3 · 1 live · Asthma · primary completion Jun 2028☆ Track
CetirizineJDP205Phase 3 · 1 live · Rhinitis, Allergic, Seasonal☆ Track
DiphenhydraminePhase 3 · 1 live · Sleep Initiation and Maintenance Disorders☆ Track
F027Phase 3 · 1 live · Diabetes Mellitus, Type 2 · primary completion Aug 2028☆ Track

3 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Lunan Pharmaceutical Group’s own registered studies; Lunan Pharmaceutical Group’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Lunan Pharmaceutical Group’s studies test, most open studies first — 12 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 2 more

Coming up

4 of Lunan Pharmaceutical Group’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. J’27
  4. 1F
  5. M
  6. A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 4 to your calendar (.ics) → With an account.

All 39 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1949%Recruiting 9 · Not yet recruiting 8 · Enrolling by invitation 2
  • Completed923%
  • Status unknown or other1128%

Phase

  • Phase 215
  • Phase 312
  • Phase 19
  • Phase 42

Where

Over the years

  1. 17
  2. 18
  3. 19
  4. 20
  5. 21
  6. 22
  7. 23
  8. 924
  9. 25
  10. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Lunan Pharmaceutical Group.

  • Shandong New Time Pharmaceutical Co., LTD
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    35 studies →
  • Lunan Better Pharmaceutical Co., LTD.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →

Studies

Recruiting first, then most recently updated. Showing 39 of 39.